Tekla Life Sciences Investors (HQL) 27.40 $HQL
Pharma And Biotech Funds Add Zest To Your Portfolio
John Dowdee - at Seeking Alpha - Fri Feb 13, 7:10AM CST
PBE: 52.78 (+0.30), HQL: 27.40 (+0.16), FBT: 110.21 (+1.02), PJP: 73.81 (+0.69), XBI: 203.40 (+1.36), XPH: 118.58 (+0.98), IBB: 323.46 (+3.04), HQH: 34.20 (+0.06)
Shares of HQL Up 16.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 09, 9:17AM CST
SmarTrend identified an Uptrend for H&Q Life Sciences Investors (NYSE:HQL) on October 21st, 2014 at $22.68. In approximately 4 months, H&Q Life Sciences Investors has returned 16.49% as of today's recent price of $26.42.
HQL: 27.40 (+0.16)
H&Q Life Sciences Investors Up 19.2% Since SmarTrend Uptrend Call (HQL)
Comtex SmarTrend(R) - Fri Jan 30, 4:39PM CST
SmarTrend identified an Uptrend for H&Q Life Sciences Investors (NYSE:HQL) on October 21st, 2014 at $22.68. In approximately 3 months, H&Q Life Sciences Investors has returned 19.18% as of today's recent price of $27.03.
HQL: 27.40 (+0.16)
Tekla Healthcare Opportunities Fund Pays Distribution
Business Wire - Fri Jan 30, 3:44PM CST
On January 30, 2015, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.1125 per share. It is currently estimated that this distribution is derived from short-term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $132,486,213, of which $103,427,424 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), THQ: 20.15 (+0.10), HQH: 34.20 (+0.06)
H&Q Life Sciences Investors Shares Up 16.8% Since SmarTrend's Buy Recommendation (HQL)
Comtex SmarTrend(R) - Fri Jan 16, 9:41AM CST
SmarTrend identified an Uptrend for H&Q Life Sciences Investors (NYSE:HQL) on October 21st, 2014 at $22.68. In approximately 3 months, H&Q Life Sciences Investors has returned 16.75% as of today's recent price of $26.48.
HQL: 27.40 (+0.16)
7 Dividend Stocks For 2015
Harry Domash - Seeking Alpha - Wed Jan 14, 12:04PM CST
It's that time of year again. I'm going to suggest seven stocks for you to consider for 2015. Last year's list averaged a disappointing 6% return, far short of the S&P 500's 12% return for the year. My portfolio's returns were squashed by...
MIC: 76.58 (+1.26), HQL: 27.40 (+0.16), HPT: 32.09 (-0.32), WFC: 55.33 (+0.47), SIX: 45.11 (-0.05), DOC: 16.85 (+0.24), CNK: 38.93 (-0.14)
Tekla Healthcare Investors Pays Distribution
Business Wire - Wed Dec 31, 11:25AM CST
On December 31, 2014, Tekla Healthcare Investors paid a quarterly stock distribution of $0.59 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $500,963,482, of which $504,847,623 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), HQH: 34.20 (+0.06)
Tekla Life Sciences Investors Pays Distribution
Business Wire - Wed Dec 31, 11:25AM CST
On December 31, 2014, Tekla Life Sciences Investors paid a quarterly stock distribution of $0.47 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $209,374,949, of which $208,409,663 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), HQH: 34.20 (+0.06)
Uptrend Call Working As H&Q Life Sciences Investors Stock Rises 16.4% (HQL)
Comtex SmarTrend(R) - Fri Dec 19, 9:49AM CST
SmarTrend identified an Uptrend for H&Q Life Sciences Investors (NYSE:HQL) on October 21st, 2014 at $22.68. In approximately 2 months, H&Q Life Sciences Investors has returned 16.36% as of today's recent price of $26.39.
HQL: 27.40 (+0.16)
CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
Business Wire - Mon Dec 08, 9:00AM CST
CardioKinetix, Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced today that it has completed a $50 million financing led by Edwards Lifesciences Corporation, with participation from existing investors U.S. Venture Partners, Tekla Healthcare Investors (NYSE:HQH), Tekla Life Sciences Investors (NYSE:HQL), SV Life Sciences, Panorama Capital, New Leaf Venture Partners, and Lexington Private Equity.
HQL: 27.40 (+0.16), EW: 134.23 (+1.89), HQH: 34.20 (+0.06)
H&Q Life Sciences Investors Has Returned 13.8% Since SmarTrend Recommendation (HQL)
Comtex SmarTrend(R) - Thu Dec 04, 10:00AM CST
SmarTrend identified an Uptrend for H&Q Life Sciences Investors (NYSE:HQL) on October 21st, 2014 at $22.68. In approximately 1 month, H&Q Life Sciences Investors has returned 13.80% as of today's recent price of $25.81.
HQL: 27.40 (+0.16)
Tekla Healthcare Opportunities Introduces Fact Card
Business Wire - Tue Nov 18, 10:44AM CST
Tekla Healthcare Opportunities Fund (NYSE: THQ) is pleased to introduce its first fact card. The fact card, which summarizes Fund information which may include quarterly data regarding the Fund including performance, portfolio holdings and sector information, will be available at www.teklacap.com or by request from the Fund's marketing and support services agent, Destra Capital Investments at (877)855-3434. The Fund intends to publish and distribute fact cards with quarterly data within approximately 15 days after each quarter's end. Please visit the Fund's website or call Destra Capital Investments to obtain the Fund's fact cards as published.
HQL: 27.40 (+0.16), THQ: 20.15 (+0.10), HQH: 34.20 (+0.06)
Tekla Life Sciences Investors Declares Stock Distribution
Business Wire - Fri Nov 14, 9:37AM CST
On November 14, 2014, Tekla Life Sciences Investors (formerly H&Q Life Sciences Investors) declared a stock distribution of $0.47 per share. The record date for the stock distribution is November 26, 2014 and the payable date is December 31, 2014. The Fund will trade ex-distribution on November 24, 2014.
HQL: 27.40 (+0.16)
Equity CEFs: Funds To Buy And Sell Heading Into 2015
Douglas Albo - at Seeking Alpha - Mon Oct 27, 4:56PM CDT
ETG: 16.61 (+0.10), KYE: 26.13 (-0.18), AWP: 6.81 (-0.02), HQL: 27.40 (+0.16), SCD: 16.98 (-0.05), CEM: 26.42 (+0.18), ETO: 24.35 (+0.27), PGP: 21.63 (+0.17), SPY: 209.78 (+0.86), EVT: 20.89 (+0.03), RFI: 13.35 (-0.02), GRX: 10.81 (-0.04), NTG: 26.13 (+0.13), UTF: 23.01 (+0.07), HQH: 34.20 (+0.06), RQI: 12.36 (-0.10)
Pharma And Biotech Funds Add Zest To Your Portfolio
John Dowdee - at Seeking Alpha - Fri Feb 13, 7:10AM CST
PBE: 52.78 (+0.30), HQL: 27.40 (+0.16), FBT: 110.21 (+1.02), PJP: 73.81 (+0.69), XBI: 203.40 (+1.36), XPH: 118.58 (+0.98), IBB: 323.46 (+3.04), HQH: 34.20 (+0.06)
Shares of HQL Up 16.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 09, 9:17AM CST
SmarTrend identified an Uptrend for H&Q Life Sciences Investors (NYSE:HQL) on October 21st, 2014 at $22.68. In approximately 4 months, H&Q Life Sciences Investors has returned 16.49% as of today's recent price of $26.42.
HQL: 27.40 (+0.16)
H&Q Life Sciences Investors Up 19.2% Since SmarTrend Uptrend Call (HQL)
Comtex SmarTrend(R) - Fri Jan 30, 4:39PM CST
SmarTrend identified an Uptrend for H&Q Life Sciences Investors (NYSE:HQL) on October 21st, 2014 at $22.68. In approximately 3 months, H&Q Life Sciences Investors has returned 19.18% as of today's recent price of $27.03.
HQL: 27.40 (+0.16)
Tekla Healthcare Opportunities Fund Pays Distribution
Business Wire - Fri Jan 30, 3:44PM CST
On January 30, 2015, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.1125 per share. It is currently estimated that this distribution is derived from short-term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $132,486,213, of which $103,427,424 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), THQ: 20.15 (+0.10), HQH: 34.20 (+0.06)
H&Q Life Sciences Investors Shares Up 16.8% Since SmarTrend's Buy Recommendation (HQL)
Comtex SmarTrend(R) - Fri Jan 16, 9:41AM CST
SmarTrend identified an Uptrend for H&Q Life Sciences Investors (NYSE:HQL) on October 21st, 2014 at $22.68. In approximately 3 months, H&Q Life Sciences Investors has returned 16.75% as of today's recent price of $26.48.
HQL: 27.40 (+0.16)
7 Dividend Stocks For 2015
Harry Domash - Seeking Alpha - Wed Jan 14, 12:04PM CST
It's that time of year again. I'm going to suggest seven stocks for you to consider for 2015. Last year's list averaged a disappointing 6% return, far short of the S&P 500's 12% return for the year. My portfolio's returns were squashed by...
MIC: 76.58 (+1.26), HQL: 27.40 (+0.16), HPT: 32.09 (-0.32), WFC: 55.33 (+0.47), SIX: 45.11 (-0.05), DOC: 16.85 (+0.24), CNK: 38.93 (-0.14)
Tekla Healthcare Investors Pays Distribution
Business Wire - Wed Dec 31, 11:25AM CST
On December 31, 2014, Tekla Healthcare Investors paid a quarterly stock distribution of $0.59 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $500,963,482, of which $504,847,623 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), HQH: 34.20 (+0.06)
Tekla Life Sciences Investors Pays Distribution
Business Wire - Wed Dec 31, 11:25AM CST
On December 31, 2014, Tekla Life Sciences Investors paid a quarterly stock distribution of $0.47 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $209,374,949, of which $208,409,663 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), HQH: 34.20 (+0.06)
Uptrend Call Working As H&Q Life Sciences Investors Stock Rises 16.4% (HQL)
Comtex SmarTrend(R) - Fri Dec 19, 9:49AM CST
SmarTrend identified an Uptrend for H&Q Life Sciences Investors (NYSE:HQL) on October 21st, 2014 at $22.68. In approximately 2 months, H&Q Life Sciences Investors has returned 16.36% as of today's recent price of $26.39.
HQL: 27.40 (+0.16)
CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
Business Wire - Mon Dec 08, 9:00AM CST
CardioKinetix, Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced today that it has completed a $50 million financing led by Edwards Lifesciences Corporation, with participation from existing investors U.S. Venture Partners, Tekla Healthcare Investors (NYSE:HQH), Tekla Life Sciences Investors (NYSE:HQL), SV Life Sciences, Panorama Capital, New Leaf Venture Partners, and Lexington Private Equity.
HQL: 27.40 (+0.16), EW: 134.23 (+1.89), HQH: 34.20 (+0.06)
H&Q Life Sciences Investors Has Returned 13.8% Since SmarTrend Recommendation (HQL)
Comtex SmarTrend(R) - Thu Dec 04, 10:00AM CST
SmarTrend identified an Uptrend for H&Q Life Sciences Investors (NYSE:HQL) on October 21st, 2014 at $22.68. In approximately 1 month, H&Q Life Sciences Investors has returned 13.80% as of today's recent price of $25.81.
HQL: 27.40 (+0.16)
Tekla Healthcare Opportunities Introduces Fact Card
Business Wire - Tue Nov 18, 10:44AM CST
Tekla Healthcare Opportunities Fund (NYSE: THQ) is pleased to introduce its first fact card. The fact card, which summarizes Fund information which may include quarterly data regarding the Fund including performance, portfolio holdings and sector information, will be available at www.teklacap.com or by request from the Fund's marketing and support services agent, Destra Capital Investments at (877)855-3434. The Fund intends to publish and distribute fact cards with quarterly data within approximately 15 days after each quarter's end. Please visit the Fund's website or call Destra Capital Investments to obtain the Fund's fact cards as published.
HQL: 27.40 (+0.16), THQ: 20.15 (+0.10), HQH: 34.20 (+0.06)
Tekla Life Sciences Investors Declares Stock Distribution
Business Wire - Fri Nov 14, 9:37AM CST
On November 14, 2014, Tekla Life Sciences Investors (formerly H&Q Life Sciences Investors) declared a stock distribution of $0.47 per share. The record date for the stock distribution is November 26, 2014 and the payable date is December 31, 2014. The Fund will trade ex-distribution on November 24, 2014.
HQL: 27.40 (+0.16)
Equity CEFs: Funds To Buy And Sell Heading Into 2015
Douglas Albo - at Seeking Alpha - Mon Oct 27, 4:56PM CDT
ETG: 16.61 (+0.10), KYE: 26.13 (-0.18), AWP: 6.81 (-0.02), HQL: 27.40 (+0.16), SCD: 16.98 (-0.05), CEM: 26.42 (+0.18), ETO: 24.35 (+0.27), PGP: 21.63 (+0.17), SPY: 209.78 (+0.86), EVT: 20.89 (+0.03), RFI: 13.35 (-0.02), GRX: 10.81 (-0.04), NTG: 26.13 (+0.13), UTF: 23.01 (+0.07), HQH: 34.20 (+0.06), RQI: 12.36 (-0.10)
